1-8360443-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001042681.2(RERE):​c.3064C>G​(p.Pro1022Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1022S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0055 ( 8 hom., cov: 17)
Exomes 𝑓: 0.00063 ( 12 hom. )

Consequence

RERE
NM_001042681.2 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.67

Publications

1 publications found
Variant links:
Genes affected
RERE (HGNC:9965): (arginine-glutamic acid dipeptide repeats) This gene encodes a member of the atrophin family of arginine-glutamic acid (RE) dipeptide repeat-containing proteins. The encoded protein co-localizes with a transcription factor in the nucleus, and its overexpression triggers apoptosis. A similar protein in mouse associates with histone deacetylase and is thought to function as a transcriptional co-repressor during embryonic development. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
RERE Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder with or without congenital anomalies
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder with or without anomalies of the brain, eye, or heart
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027897656).
BP6
Variant 1-8360443-G-C is Benign according to our data. Variant chr1-8360443-G-C is described in ClinVar as Benign. ClinVar VariationId is 445630.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00553 (774/139868) while in subpopulation AFR AF = 0.0202 (751/37116). AF 95% confidence interval is 0.019. There are 8 homozygotes in GnomAd4. There are 342 alleles in the male GnomAd4 subpopulation. Median coverage is 17. This position passed quality control check.
BS2
High AC in GnomAd4 at 774 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RERENM_001042681.2 linkc.3064C>G p.Pro1022Ala missense_variant Exon 18 of 23 ENST00000400908.7 NP_001036146.1 Q9P2R6-1
RERENM_012102.4 linkc.3064C>G p.Pro1022Ala missense_variant Exon 19 of 24 NP_036234.3 Q9P2R6-1
RERENM_001042682.2 linkc.1402C>G p.Pro468Ala missense_variant Exon 8 of 13 NP_001036147.1 Q9P2R6-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
REREENST00000400908.7 linkc.3064C>G p.Pro1022Ala missense_variant Exon 18 of 23 1 NM_001042681.2 ENSP00000383700.2 Q9P2R6-1

Frequencies

GnomAD3 genomes
AF:
0.00555
AC:
776
AN:
139774
Hom.:
8
Cov.:
17
show subpopulations
Gnomad AFR
AF:
0.0203
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000985
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000745
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000156
Gnomad OTH
AF:
0.00261
GnomAD2 exomes
AF:
0.00148
AC:
57
AN:
38408
AF XY:
0.00135
show subpopulations
Gnomad AFR exome
AF:
0.0150
Gnomad AMR exome
AF:
0.000282
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000699
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000632
AC:
519
AN:
821502
Hom.:
12
Cov.:
12
AF XY:
0.000564
AC XY:
230
AN XY:
408144
show subpopulations
African (AFR)
AF:
0.0229
AC:
417
AN:
18202
American (AMR)
AF:
0.000625
AC:
9
AN:
14404
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15150
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29218
South Asian (SAS)
AF:
0.000327
AC:
16
AN:
48940
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29840
Middle Eastern (MID)
AF:
0.000379
AC:
1
AN:
2642
European-Non Finnish (NFE)
AF:
0.0000272
AC:
17
AN:
625714
Other (OTH)
AF:
0.00158
AC:
59
AN:
37392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.626
Heterozygous variant carriers
0
21
41
62
82
103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00553
AC:
774
AN:
139868
Hom.:
8
Cov.:
17
AF XY:
0.00505
AC XY:
342
AN XY:
67778
show subpopulations
African (AFR)
AF:
0.0202
AC:
751
AN:
37116
American (AMR)
AF:
0.000984
AC:
14
AN:
14226
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3326
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4564
South Asian (SAS)
AF:
0.000746
AC:
3
AN:
4024
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
276
European-Non Finnish (NFE)
AF:
0.0000156
AC:
1
AN:
63976
Other (OTH)
AF:
0.00259
AC:
5
AN:
1934
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.573
Heterozygous variant carriers
0
33
66
99
132
165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000253
Hom.:
0
Bravo
AF:
0.00776
ESP6500AA
AF:
0.00725
AC:
10
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000948
AC:
45

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 30, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

RERE-related disorder Benign:1
Mar 13, 2023
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
13
DANN
Benign
0.33
DEOGEN2
Benign
0.13
T;.;.;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.67
.;T;T;T
MetaRNN
Benign
0.0028
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M;.;.;M
PhyloP100
1.7
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-1.5
N;N;N;N
REVEL
Benign
0.085
Sift
Benign
0.068
T;T;T;T
Sift4G
Uncertain
0.026
D;T;D;D
Polyphen
0.0020
B;B;.;B
Vest4
0.24
MVP
0.56
MPC
0.34
ClinPred
0.022
T
GERP RS
-1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Varity_R
0.028
gMVP
0.18
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202121539; hg19: chr1-8420503; API